Status:

RECRUITING

Development and Testing of imHere4U: A Digital Suicide Prevention Intervention for Cyberbullied Adolescents

Lead Sponsor:

University of Pittsburgh

Collaborating Sponsors:

National Institute of Mental Health (NIMH)

Conditions:

Psychological Distress

Suicidal Ideation

Eligibility:

All Genders

12-17 years

Phase:

NA

Brief Summary

The objective of this study is to test the feasibility and preliminary efficacy of Flourish (formerly referred to as imHere4U), a digital suicide prevention intervention for cyberbullied adolescents. ...

Detailed Description

Assessment Visits: As part of this study, adolescents will participate in four assessment visits at baseline and 4, 12, and 24 weeks following onboarding to the study intervention. Assessments cover ...

Eligibility Criteria

Inclusion

  • English-speaking
  • access to a phone or device capable of text messaging
  • past 3-month history of cyberbullying assessed by the cybervictimization subscale of the Traditional Bullying and Cyberbullying Victimization and Perpetration Scale and/or presence of online discrimination measured by a modified version of a discrimination measured developed as part of the Adolescent Brain and Cognitive Development (ABCD) study
  • past 3-month history of suicidal risk, including: psychological distress (\>13 on the 6-item Kessler Psychological Distress Scale) and/or suicidal ideation or behavior (via the Columbia Suicide Severity Rating Scale)

Exclusion

  • intellectual challenges, low literacy levels, or other conditions that might inhibit adolescents' ability to effectively engage with Flourish (reported by parents and, if needed, confirmed through the age-appropriate Wechsler Intelligence scale)
  • acuity levels suggesting need for a higher level of care (e.g., inpatient hospitalization) or referral for emergency services

Key Trial Info

Start Date :

November 21 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2026

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT06002191

Start Date

November 21 2023

End Date

August 1 2026

Last Update

September 11 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States, 15213